Clinical Practice Guidelines

June 23, 2016

Re: Release of Clinical Practice Guidelines to the public

Dear CFAS Members,

The Board of Directors recently discussed the merits of making Clinical Practice Guidelines available and accessible to the general public. Currently, Guidelines only available to active members in good standing on the member section of the CFAS website.  Consistent with our values of providing transparency, the Board concluded that Clinical Practice Guidelines should be made accessible to the public on the non-member section of the CFAS web site.  This decision is consistent with practices followed by ASRM and ESHRE.

There will be an ordered process by which documents will be made available to the public.  First, the office of the CFAS will announce the publication of a Clinical Practice Guideline to members only.  (Members will already have had opportunity to provide input to the documents as part of the development process).   A week or so following the member communication, the office will issue a press release, if appropriate, announcing the publication of a new clinical practice guideline by the Society.   The purpose of the media release is to the promote the leadership role of the CFAS and to allow for coordinated media interviews by CFAS spokespersons on the specific guideline.

Each Guideline published by the CFAS will contain the following statement outlining the intended use and limitations of a guideline.

This document is based on available evidence to date, often in a rapidly advancing field of study. Recommendations may not reflect emerging evidence and are subject to change. Clinical guidelines are intended as an aid to clinical judgement, and not to replace it. Clinical guidelines do not prevent clinicians from exercising freedom in their good clinical practice, nor relieve them of their responsibility to make appropriate decisions based on their own knowledge and experience.

All rights reserved © 2016 Canadian Fertility and Andrology Society. This document may not be reproduced in its entirety or in part without the expressed written consent of the Canadian Fertility and Andrology Society.

The CFAS will publish French and English versions of the guideline along with a summary for lay readers.  Guidelines related to individual Special Interest Groups will not automatically be made public.

During the week of June 27th, the CFAS will announce its decision to release guidelines to the public and will announce the release of Guidelines for Third Party Reproduction.  The intent of this correspondence is to give members advanced notice of this new directive.

We trust that members will be supportive of this initiative.

Yours Sincerely,
Mark G. Evans
Executive Director
On behalf of the Board of Directors of the CFAS